Australia is carefully awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://giant-escape-bike764415.realblogstories.com/313479/novo-nordisk-s-retatrutide-australia-a-new-hope-for-losing-weight